Global Contraceptive Devices Market Size, Share & Trends Analysis Report, By Device Types (Condoms, Intrauterine device (IUDs), Injectables, Patches, Vaginal Rings, Diaphragms, Cervical Caps, Sponges, Others), By Distribution (Supermarkets, Hypermarkets,

Global Contraceptive Devices Market Size, Share & Trends Analysis Report, By Device Types (Condoms, Intrauterine device (IUDs), Injectables, Patches, Vaginal Rings, Diaphragms, Cervical Caps, Sponges, Others), By Distribution (Supermarkets, Hypermarkets, and Convenience Stores; Retail and Hospital Pharmacies and Drug Stores; Online Stores; and Others), By Region (North America, Europe, APAC, and Others), and Segment Forecasts, 2023 – 2030



Global Contraceptive Devices Market Size, Share & Trends Analysis Report, By Device Types (Condoms, Intrauterine device (IUDs), Injectables, Patches, Vaginal Rings, Diaphragms, Cervical Caps, Sponges, Others), By Distribution (Supermarkets, Hypermarkets, and Convenience Stores; Retail and Hospital Pharmacies and Drug Stores; Online Stores; and Others), By Region (North America, Europe, APAC, and Others), and Segment Forecasts, 2023 - 2030

The Global Contraceptive Devices Market was valued at US $16.56 billion in 2022 and is expected to reach US $26.52 billion by 2030, growing at a CAGR of 6.06% during the forecast period 2023 – 2030.

Any device used to intentionally prevent pregnancy is called a contraceptive device. Contraception is a way of doing so. Apart from its principal function of preventing unwanted pregnancies, the contraceptive device also aids in safeguarding against sexually transmitted infections (STDs) during sexual activity. There are two different kinds of contraceptive devices: hormonal and barrier contraceptive.

The way barrier contraceptive methods work is by physically blocking sperm from entering the uterus of a woman. This category includes spermicides such foams, creams, and suppositories, as well as a variety of contraceptive devices like condoms, diaphragms, cervical caps, contraceptive sponges, and gels. Contrarily, hormonal contraceptive methods use either progestin alone or in combination with oestrogen. These methods mostly work to stop conception by blocking ovulation, or the release of eggs from the ovaries, or by thickening cervical mucus, which blocks sperm from passing through the cervix and into the uterus. This category includes treatments such as skin patches, injections, vaginal rings, implants, and intrauterine devices (IUDs).

Because they may consistently and appropriately prevent unwanted births, contraceptive methods have become more and more popular over time. In addition, the increasing acceptance and popularity of contraceptive methods in various societies and cultures can be attributed to a number of factors, including gender equity, empowerment, health benefits, STD prevention, education and awareness, and economic considerations. These factors enable people to exercise their right to plan their families and live healthier lives.

“Condom automation segment, by type, to be largest market from 2023 to 2030.”

By type, the Global Contraceptive Devices Market comprises of namely condoms, IUDs (both hormonal and copper), injectables, patches, vaginal rings, diaphragms, cervical caps, sponges, and others. Other is further divided into contraceptive gels and spermicides (foams, creams, and suppositories). With a market share of 52.36%, the condom segment led the contraceptive devices market in 2022. This was due to a number of factors, including their affordability and easy availability, their efficacy, and additional benefits like dual protection, which refers to the fact that condoms serve as a barrier method for both STI prevention and contraception. With a projected compound annual growth rate (CAGR) of 8.15%, IUDs are the fastest-growing market segment. IUDs are among the best methods of birth control now on the market. Their very low failure rate adds to their allure for people looking for dependable birth control.

“Supermarkets, hypermarkets, and convenience stores segment, by distribution channel, to be largest market from 2023 to 2030.”

By distribution channel, the global Contraceptive Devices Market is divided into supermarkets, hypermarkets, and convenience stores; retail pharmacies, hospital pharmacies and drug stores; online stores; and others. The others segment is further divided into hospitals, clinics, medical institutions, family planning organizations, and nonprofits. The market for contraceptive devices in 2022 was controlled by the supermarket, hypermarket, and convenience store segments. The fact that these stores protect customer privacy is one of the reasons for its huge share. One can attain a degree of anonymity by purchasing contraceptive devices from these kinds of outlets that might be more difficult to do in other contexts. With a CAGR of 7.32% over the course of the projected period, the online retailers segment is the one that is expanding at the highest rate. It is possible to relate this rise to elements like convenience. The ease of buying from home or anyplace with internet access is provided by online retailers. Without having to go to a physical store, consumers may browse and buy contraceptive products like condoms, vaginal rings, patches, and more. Additionally, some customers might prefer the level of privacy offered by purchasing contraceptive devices online. They can boost market sales by avoiding the possible pain or humiliation that comes with making in-person purchases of these goods.

“North America to be largest region in Contraceptive Devices Market.”

In 2022, the contraceptive devices market was dominated by the North American region. Increased contraceptive device purchases are a result of North America's stable economy, rising disposable income, and abundance of contraceptive options.

With a projected compound annual growth rate (CAGR) of 7.45%, the APAC region is the fastest-growing area in this analysis. More people and couples in the APAC region will be looking for safe contraception choices as family planning and reproductive health education and awareness continue to advance.

Contraceptive Devices Competitive Landscape

The competitive landscape of the Contraceptive Devices Market involves assessing the competitive landscape to understand the strengths, weaknesses, opportunities, and threats of the industry. Key industry players have recognized that the adoption of Contraceptive Devices technology holds the potential for further growth. The growing desire among producers to optimize their production costs has spurred collaborative efforts among companies to scale up their production capacity. This strategic collaboration not only aims to increase revenue but also seeks to establish dominance in the market.

The Contraceptive Devices Market is highly competitive, with numerous companies vying for market share. Prominent companies in the Contraceptive Devices Market include:

Major Players:

Church & Dwight Co., Inc. (U.S.)

Fuji Latex Co., Ltd. (Japan)

Reckitt Benckiser Group (U.K.)

Karex Berhad (Malaysia)

Lelo (Sweden)

LifeStyles Healthcare Pte Ltd. (Belgium)

Veru, Inc. (U.S.)

Mayer Laboratories, Inc. (U.S.)

Okamoto Industries, Inc. (Japan)

Cupid Limited (India)

Caution Wear Corp. (U.S.)

ONE Condoms (U.S.)

Abbvie Inc. (U.S.)

Bayer AG (Germany)

CooperSurgical Inc. (U.S.)

EUROGINE, S.L. (Spain)

Mona Lisa N.V. (Belgium)

Pregna International Limited (India)

Prosan International B.V. (The Netherlands)

SMB Corporation of India (India)

Melbea Innovations (Hungary)

Ocon Medical Ltd. (Israel),

Viatris Inc. (U.S.)

Agile Therapeutics, Inc. (U.S.)

Luye Pharma Group (China)

Johnson & Johnson (U.S.)

Merck & Co., Inc. (U.S.)

Novo Nordisk (Denmark)

Pfizer, Inc. (U.S.)

Prasco Laboratories (U.S.)

The Cigna Group (U.S.)

Teva Pharmaceuticals, Inc. (Israel)

Tree of Life Pharma Ltd. (Israel)

The Good Glamm Group (India)

BRANDMOVER GmbH (Switzerland)

Recent Developments:

Good Glamm group-backed in May 2023 Sirona In an all-cash transaction, India purchased Bleü, the country's first vegan condom brand. Sirona has now joined the category of sexual wellness thanks to this acquisition. Prominent Femtech company Sirona is well-known for its period-tracking app on WhatsApp and its line of feminine hygiene products.

In March 2023, the sustainable Feelgood Condoms, manufactured with green power and vegan ingredients, were introduced by the Swiss business Brandmover. The brand's tagline is ""Not only for vegans & animal lovers: Feelgood satisfies everyone.""

The first non-latex condoms from Durex were introduced in March 2023. They are composed of polyisoprene, which is said to be softer than latex rubber and give partners a skin-on-skin experience. The brand wants to redefine the sensory experience of safe intimacy by improving the depth and calibre of intimate encounters while guaranteeing protection.

SEX BRAND, launched its SECONDSKIN condom in February 2023. The material used to make it is bio-mimetic lubricated rubber, which is 34% thinner than regular condoms. Not only does the condom replicate the feel of real skin, but it also carries with it a strong commitment to improving society and the environment because it is a vegan subscription condom, created with a fully transparent and innovative sustainable rubber source as part of the Regenerative Rubber Initiative. Surprisingly, SEX BRAND promises to donate an additional million condoms to Uganda for each million condoms sold, filling a critical 27% shortage of supplies for sexual wellness for marginalised populations.


1 Introduction Of Global Contraceptive Devices Market
1.1 Overview Of The Market
1.2 Scope Of Report
1.3 Assumptions
 
2 Executive Summary
 
3 Research Methodology
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List Of Data Sources
 
4 Global Contraceptive Devices Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.3.1. Bargaining Power Of Suppliers
4.3.2. Threat Of New Entrants
4.3.3. Threat Of Substitutes
4.3.4. Competitive Rivalry
4.3.5. Bargaining Power Among Buyers
4.4 Value Chain Analysis
 
5 Global Contraceptive Devices Market, By Types
5.1 Overview
5.2 Condoms
5.3 Iuds
5.4 Injectables
5.5 Patches
5.6 Vaginal Rings
5.7 Diaphragms
5.8 Cervical Caps
5.9 Sponges
5.10 Others
 
6 Global Contraceptive Devices Market, By Distribution Channels
6.1 Supermarkets, Hypermarkets, And Convenience Stores
6.2 Retail Pharmacies, Hospital Pharmacies And Drug Stores
6.3 Online Stores
6.4 Others
 
7 Global Contraceptive Devices Market, By Region
7.1 North America
7.1.1 U.S.
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.3 U.K.
7.2.4 France
7.2.5 Rest Of Europe
7.3 Asia Pacific
7.3.1 China
7.3.2 Japan
7.3.3 India
7.3.4 South Korea
7.3.5 Singapore
7.3.6 Malaysia
7.3.7 Australia
7.3.8 Thailand
7.3.9 Indonesia
7.3.10 Philippines
7.3.11 Rest Of Asia Pacific
7.4 Others
7.4.1 Saudi Arabia
7.4.2 U.A.E.
7.4.3 South Africa
7.4.4 Egypt
7.4.5 Israel
7.4.6 Rest Of Middle East And Africa (Mea)
7.4.7 Brazil
7.4.8 Argentina
7.4.9 Mexico
7.4.10 Rest Of South America
 
8 Company Profiles
8.1 Church & Dwight Co. Inc.
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Financial Performance (As Per Availability)
8.1.6 Key News
 
9.1 Fuji Latex Co., Ltd.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Operating Business Segments
9.1.4. Product Portfolio
9.1.5. Financial Performance (As Per Availability)
9.1.6 Key News
 
10.1 Reckitt Benckiser Group
10.1.1. Company Overview
10.1.2. Key Executives
10.1.3. Operating Business Segments
10.1.4. Product Portfolio
10.1.5. Financial Performance (As Per Availability)
10.1.6 Key News
 
11.1 Karex Berhad
11.1.1. Company Overview
11.1.2. Key Executives
11.1.3. Operating Business Segments
11.1.4. Product Portfolio
11.1.5. Financial Performance (As Per Availability)
11.1.6 Key News
 
12.1 Lelo
12.1.1. Company Overview
12.1.2. Key Executives
12.1.3. Operating Business Segments
12.1.4. Product Portfolio
12.1.5. Financial Performance (As Per Availability)
12.1.6 Key News
 
13.1 Lifestyles Healthcare Pte Ltd.
13.1.1. Company Overview
13.1.2. Key Executives
13.1.3. Operating Business Segments
13.1.4. Product Portfolio
13.1.5. Financial Performance (As Per Availability)
13.1.6 Key News
 
14.1 Veru, Inc.
14.1.1. Company Overview
14.1.2. Key Executives
14.1.3. Operating Business Segments
14.1.4. Product Portfolio
14.1.5. Financial Performance (As Per Availability)
14.1.6 Key News
 
15.1 Mayer Laboratories, Inc.
15.1.1. Company Overview
15.1.2. Key Executives
15.1.3. Operating Business Segments
15.1.4. Product Portfolio
15.1.5. Financial Performance (As Per Availability)
15.1.6 Key News
 
16.1 Okamoto Industries, Inc.
16.1.1. Company Overview
16.1.2. Key Executives
16.1.3. Operating Business Segments
16.1.4. Product Portfolio
16.1.5. Financial Performance (As Per Availability)
16.1.6 Key News
 
17.1 Cupid Limited
17.1.1. Company Overview
17.1.2. Key Executives
17.1.3. Operating Business Segments
17.1.4. Product Portfolio
17.1.5. Financial Performance (As Per Availability)
17.1.6 Key News
 
18.1 Caution Wear Corp.
18.1.1. Company Overview
18.1.2. Key Executives
18.1.3. Operating Business Segments
18.1.4. Product Portfolio
18.1.5. Financial Performance (As Per Availability)
18.1.6 Key News
 
19.1 One Condoms
19.1.1. Company Overview
19.1.2. Key Executives
19.1.3. Operating Business Segments
19.1.4. Product Portfolio
19.1.5. Financial Performance (As Per Availability)
19.1.6 Key News
 
20.1 Abbvie Inc.
20.1.1. Company Overview
20.1.2. Key Executives
20.1.3. Operating Business Segments
20.1.4. Product Portfolio
20.1.5. Financial Performance (As Per Availability)
20.1.6 Key News
 
21.1 Bayer Ag
21.1.1. Company Overview
21.1.2. Key Executives
21.1.3. Operating Business Segments
21.1.4. Product Portfolio
21.1.5. Financial Performance (As Per Availability)
21.1.6 Key News
 
22.1 Coopersurgical Inc.
22.1.1. Company Overview
22.1.2. Key Executives
22.1.3. Operating Business Segments
22.1.4. Product Portfolio
22.1.5. Financial Performance (As Per Availability)
22.1.6 Key News
 
23.1 Eurogine, S.L.
23.1.1. Company Overview
23.1.2. Key Executives
23.1.3. Operating Business Segments
23.1.4. Product Portfolio
23.1.5. Financial Performance (As Per Availability)
23.1.6 Key News
 
24.1 Mona Lisa N.V.
24.1.1. Company Overview
24.1.2. Key Executives
24.1.3. Operating Business Segments
24.1.4. Product Portfolio
24.1.5. Financial Performance (As Per Availability)
24.1.6 Key News
 
25.1 Pregna International Limited
25.1.1. Company Overview
25.1.2. Key Executives
25.1.3. Operating Business Segments
25.1.4. Product Portfolio
25.1.5. Financial Performance (As Per Availability)
25.1.6 Key News
 
26.1 Prosan International B.V.
26.1.1. Company Overview
26.1.2. Key Executives
26.1.3. Operating Business Segments
26.1.4. Product Portfolio
26.1.5. Financial Performance (As Per Availability)
26.1.6 Key News
 
27.1 Smb Corporation Of India
27.1.1. Company Overview
27.1.2. Key Executives
27.1.3. Operating Business Segments
27.1.4. Product Portfolio
27.1.5. Financial Performance (As Per Availability)
27.1.6 Key News
 
28.1 Melbea Innovations
28.1.1. Company Overview
28.1.2. Key Executives
28.1.3. Operating Business Segments
28.1.4. Product Portfolio
28.1.5. Financial Performance (As Per Availability)
28.1.6 Key News
 
29.1 Ocon Medical Ltd.
29.1.1. Company Overview
29.1.2. Key Executives
29.1.3. Operating Business Segments
29.1.4. Product Portfolio
29.1.5. Financial Performance (As Per Availability)
29.1.6 Key News
 
30.1 Viatris Inc.
30.1.1. Company Overview
30.1.2. Key Executives
30.1.3. Operating Business Segments
30.1.4. Product Portfolio
30.1.5. Financial Performance (As Per Availability)
30.1.6 Key News
 
31.1 Agile Therapeutics, Inc.
31.1.1. Company Overview
31.1.2. Key Executives
31.1.3. Operating Business Segments
31.1.4. Product Portfolio
31.1.5. Financial Performance (As Per Availability)
31.1.6 Key News
 
32.1 Luye Pharma Group
32.1.1. Company Overview
32.1.2. Key Executives
32.1.3. Operating Business Segments
32.1.4. Product Portfolio
32.1.5. Financial Performance (As Per Availability)
32.1.6 Key News
 
33.1 Johnson & Johnson
33.1.1. Company Overview
33.1.2. Key Executives
33.1.3. Operating Business Segments
33.1.4. Product Portfolio
33.1.5. Financial Performance (As Per Availability)
33.1.6 Key News
 
34.1 Merck & Co., Inc.
34.1.1. Company Overview
34.1.2. Key Executives
34.1.3. Operating Business Segments
34.1.4. Product Portfolio
34.1.5. Financial Performance (As Per Availability)
34.1.6 Key News
 
35.1 Novo Nordisk
35.1.1. Company Overview
35.1.2. Key Executives
35.1.3. Operating Business Segments
35.1.4. Product Portfolio
35.1.5. Financial Performance (As Per Availability)
35.1.6 Key News
 
36.1 Pfizer, Inc.
36.1.1. Company Overview
36.1.2. Key Executives
36.1.3. Operating Business Segments
36.1.4. Product Portfolio
36.1.5. Financial Performance (As Per Availability)
36.1.6 Key News
 
37.1 Prasco Laboratories
37.1.1. Company Overview
37.1.2. Key Executives
37.1.3. Operating Business Segments
37.1.4. Product Portfolio
37.1.5. Financial Performance (As Per Availability)
37.1.6 Key News
 
38.1 The Cigna Group
38.1.1. Company Overview
38.1.2. Key Executives
38.1.3. Operating Business Segments
38.1.4. Product Portfolio
38.1.5. Financial Performance (As Per Availability)
38.1.6 Key News
 
39.1 Teva Pharmaceuticals, Inc.
39.1.1. Company Overview
39.1.2. Key Executives
39.1.3. Operating Business Segments
39.1.4. Product Portfolio
39.1.5. Financial Performance (As Per Availability)
39.1.6 Key News
 
40.1 Tree Of Life Pharma Ltd.
40.1.1. Company Overview
40.1.2. Key Executives
40.1.3. Operating Business Segments
40.1.4. Product Portfolio
40.1.5. Financial Performance (As Per Availability)
40.1.6 Key News
 
41.1 The Good Glamm Group
41.1.1. Company Overview
41.1.2. Key Executives
41.1.3. Operating Business Segments
41.1.4. Product Portfolio
41.1.5. Financial Performance (As Per Availability)
41.1.6 Key News
 
42.1 Brandmover Gmbh
42.1.1. Company Overview
42.1.2. Key Executives
42.1.3. Operating Business Segments
42.1.4. Product Portfolio
42.1.5. Financial Performance (As Per Availability)
42.1.6 Key News

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings